Диссертация (1154773), страница 21
Текст из файла (страница 21)
73.– - P. 82-86.102.de Bortoli N., Guidi G., Savarino E., Тhe evaluation of the efficacyof weight loss in controlling symptoms in patients with gastroesophageal refluxsymptoms / // Unated European gastroenterology journal. 2013. - Vol.1. Suppl.1. - P1031.103.DeMeester T. R. et al. Technique, indications, and clinical use of24 hour esophageal pH monitoring // J. Thorac. Cardiovasc. Surg. 1980.
– Vol.79. – P.656.104.DeMeester T. R., Johnson L. F. The evaluation of objectivemeasurements of gastroesophageal reflux and their contribution to patientmanagement // Surg. Clin. N. Amer. 1976. – Vol.56. – P.39–53.105.Dent J, Vakil N, Jones R, et al. Validation of the reflux diseasequestionnaire for the diagnosis of gastroesophageal reflux disease in primarycare.
// Gut 2007. – Vol.56(Suppl 111). – P.328.106.De Vries D.R., van Herwaarden M.A., Smout A.J. et al.Gastroesophageal pressure gradients in gastroesophageal reflux disease:relations with hiatal hernia, body mass index, and esophageal acid exposure //Am. J. Gastroenterol. 2008. - Vol.103. - Р.1349—1354148107.Dent J. From 1906 to 2006 — a century of major evolution ofunderstanding of gastrooesophageal reflux disease // Aliment. Pharmacol.Therapeut. 2006.— Vol.
24 (9).— Р. 1269—1281108.Dent J., Brun J., Fendrick A.M. An evidence-based appraisal ofreflux disease management: the Genval Workshop Report. Gut 1999. – Vol.44.– P.1-16.109.Dent J. Pathogenesis of gastroesophageal reflux disease and noveloptions for its therapy // Neurogastroenterol. Motil. 2008. – Vol. 20 (suppl. 1).– P. 91–102.110.Derakhshan M.H., Robertson E.V., Fletcher J., Jones G.R,.
LeeY.Y., Wirz A.A., McColl K.E. Mechanism of association between BMI anddysfunction of the gastro-oesophageal barrier in pa-tients with normalendoscopy. // Gut. 2012. –61(3). – P.337-343.111.El-Serag, H. B. The association between obesity and GERD: AReview of the epidemiological evidence / H. B. El-Serag // Dig. Dis. Sci. 2008.– Vol. 53(9). – P. 2307–2312.112.El-Serag H.B., Satia J.A., Rabeneck L. Dietary intake and the riskof gastro-oesophageal reflux disease: a cross sectional study in volunteers . //Gut. 2005. Vol.54(1). – P.11-17.113.El-Serag H., Graham D., Satia J.
Obesity is an independent riskfactor for GERD symptoms and erosive esophagitis. // Am. J. Gastroenterol.2005. - Vol.100. - P.1243–1250.114.El-Serag H.B. Anthropometric correlates of intragastric pressure //Scand. J. Gastroen-terol. 2006. - Vol.41. - P. 887-891.115.Eman A. Abdel-Aziz , Rasha T. et al. Health related quality of lifeand psychological problems in Egyptian children with simple obesity in relationto body mass index // Egyptian Journal of Medical Human Genetics. -2014.- V15(2).- P. 149–154116.Feneberg A.
Malfertheiner Р. Epidemic trends of obesity withimpact on metabolism and digestive diseases // Dig Dis. 2012. – 30(2):143-7.149117.Fitton A.,Wiseman L.,Pantoprazole.A review of itspharmacological properties and therapeutic use in acid-related disorders //Drugs. 1996. – Vol.51(3). - P.460-448.118.Friedman S., Grendell J. McQuaid K. Current diagnosis andtreatment in gastroenterology, 6nd edition.- USA: McGraw-Hill, 2003.119.Fuchs K. H., DeMeester T. R., Albertucci M. Specificity andsensitivity of objective diagnosis of gastroesophageal reflux disease // Surgery.1987. – Vol.102.
– P. 575–580.120.Gao L, Weck M.N., Rothenbacher D., Brenner H. Body massindex, chronic atrophic gas-tritis and heartburn: a population-based studyamong 8936 older adults from Germany. Body mass index, chronic atrophicgastritis and heartburn: a population-based study among 8936 older adults fromGermany. // Aliment Pharmacol Ther. 2010. – Vol.32(2). – P.296-302121.Gilger M.A., El-Serag H.B., Gold B.D. et al. Prevalence ofendoscopic findings of erosive esophagitis in children: a population-basedstudy. J Pediat Gastroenterol Nutr 2008. – 47(2).
- P.141—146.122.Hajar N., Castell D.O., Ghomrawi H., et al. Impedance pHconfirms the relationship between GERD and BMI. // Dig Dis Sci. 2012. —Vol. 57(7). — P. 1875-1879.123.Hampel,H.Meta-analysis:obesityandtheriskforgastroesophageal reflux disease and its complications / H. Hampel, N. S.Abraham, H. B. El-Serag // Ann. Intern. Med. 2005. – Vol. 143. – P. 199–211.124.Han M.S., Lada M.J., Nieman D.R. et al.
24-h multichannelintraluminal impedance-pH monitoring may be an inadequate test for detectinggastroesophageal reflux in patients with mixed typical and atypical symptoms.// Surg. Endosc. 2014. – Vol.3. – Р. 37–39.125.Harju E. Guar gum benefits duodenal ulcer patients by decreasinggastric acidity and rate of emptying of gastric contents 60 to 120 minutespostprandially // Am. Surg. – 1984. – Vol. 50. – P. 668–672.150126.Iovino P., Angrisani L., Galloro G.
et al. Proximal stomachfunction in obesitywith normal and abnormal oesophageal acid exposure //Neurogastroenterol. Motil. 2006.— Vol.18.— P.425-432.127.Iovino P., Angrisani L., Tremolaterra Abnormal esophageal acidexposure is common in morbidly obese patients andimproves after a successfulLapband system implantation // Surg. Endosc. 2002.— Vol.
16.— Р. 1631—1635.128.Iwakiri K., Kobayashi M., Kotoyori M. et al. Relationship betweenpostprandial esophageal acid exposure and meal volume and fat content.// DisDig Sci 1996. – Vol.41. – P.926–930.129.Kiess W., Penke М., Sergeyev E. et al. Childhood obesity at thecrossroads // Journal of Pediatric Endocrinology and Metabolism. -2015.-V.25.-P.312-330130.Keskin О, Tüzün A, Yaman A, et al.
The association betweengastroesoeai flap valve function and gastroesophageal reflux symptoms,endoscopic features, helicobacter pylori status and body mass index. // UnatedEuropean gastroenterology journal. 2013. - Vol.1. -Supplement phag 1. -P1613.131.Kim K.J., Lee B.S. Central Obesity as a Risk Factor for Non-Erosive Reflux Disease. // Yonsei Med J. 2017. – Vol.58(4). – P.743-748.132.Khan A., Kim A., Sanossian C., Francois F. Impact of obesitytreatment on gastroesophageal reflux disease. // World J Gastroenterol.
2016. –Vol.28;22(4). – P.1627-1638.133.Koebnick C. Obesity in children associated with increased risk forGERD // Int. J. Pediatr. Obes. 2010. – Vol.8. – P.3-4134.Koebnick C., Getahun D., Smith N. et al. Extreme childhoodobesity is associated with increased risk for gastroesophageal reflux disease in alarge population-based study. // Int J Pediatr Obes.
2011. – Vol.6(2-2). - e25763.151135.Lee S.W., Lien H.C., Chang C.S. et al. Impact of body mass indexand gender on quality of life in patients with gastroesophageal reflux disease //World J Gastroenterol. 2012. – Vol.28;18(36). –P.5090-5095.136.Livzan M.A., Lapteva I.V., Krolevets T.S., Kiselev I.E.
Specificfeatures of gastroesophageal reflux disease associated with obesity andoverweight. // Ter Arkh. 2016. – Vol.88(2). – P.21-27.137.Mamedova G.B., Actual problems of obesity prevention amongchildren and adolescents European. // Applied Sciences: challenges andsolutions/ 2015. – Vol. 10, 2015 P. 22-28138.Mitchell D.R., Derakhshan M.H., Wirz A.A. et al. AbdominalCompression by Waist Belt Aggravates Gastroesophageal Reflux, Primarily byImpairing Esophageal Clearance. // Gastroenterology.
2017. – Vol.152(8). –P.1881-1888.139.Mt-Isa S., Tomlin S., Sutcliffe A., Underwood M., Williamson P.,Croft N.M., Ashby D. Prokinetics prescribing in paediatrics: evidence oncisapride, domperidone, and metoclopramide. J. Pediatr.
Gastroenterol. Nutr.2015; 60 (4): 508–514.140.Mushiroda T., Douya F., Takahara E. et al. The involment of flavincontaing monooxygenase bun not CYP3A4 in metabolism of itopridehydrochloride, a gastroprokinetic agent: comparaison with cisapride andmosapride citrate // Drug Metab. Dis. 2000. - Vol.28. - Р.1231-1237.141.Nadaleto B.F., Herbella F.A., Patti M.G. Gastroesophageal refluxdisease in the obese: Pathophysiology and treatment. // Surgery. 2016.
–Vol.159(2). – P.475-486.142.Nandurkar S., Locke G.R. 3rd, Fett S. et al. Relationship betweenbody mass index, diet, exercise and gastro-oesophageal reflux symptoms in acommunity // Aliment Pharmacol Ther. 2004. – Vol.20(5). – P.497-505.143.Nelson S.P., Chen E.H., Syniar G.M. et al. Prevalence ofsymptoms of gastroesophageal reflux during infancy. A pediatric practice-based152survey. Pediatric Practice Research Group // Arch. Pediatr. Adolesc. Med.1997. – Vol.151. – P. 569–572.144.Ness-Jensen E., Hveem K., El-Serag H., Lagergren J. LifestyleIntervention in Gastroesophageal Reflux Disease.
// Clin Gastroenterol Hepatol.2016. – Vol.14(2). – Vol.175-182..145.Oh J.H., Jung S.H., Jie B.S., Oh S.H., Kim J.S., Jeon J.S., ChoiM.G. Typical symptoms rather than extraesophageal symptoms affect thequality of life in gastroesophageal reflux disease. // Turk J Gastroenterol. 2012.– Vol.23(6). - P.747-52146.Ortiz V., Ponce M., Fernandez A., Martinez B., Ponce J.L.,Garrigues V, et al. Value of heartburn for diagnosing gastroesophageal refluxdisease in severely obese patients. Obesity.
2006;14:696-700.147.Quiroga E., Cuenca%Abente F., Flum D. et al. Impairedesophageal function in morbidly obese patients with gastroesophageal refluxdisease: evaluation with multichannel intraluminal impedance // Surg. Endosc.2006.— Vol. 20.—Р. 739—743.148.Pandolfino J.E., El%Serag H.B., Zhang Q. et al. Obesity: achallenge to esophagogastric junction integrity // Gastroenterology.2006.—Vol. 130.— Р.639—649.149.Patel N.R.
et al. The association between childhood overweightand reflux esophagitis // J. Obes. – 2010; 2010: pii. 136909.150.Pehl C., Waizenhoefer A., Wendl B. et al. Effect of low and highfat meals on lower esophageal sphincter motility and gastroesophageal reflux inhealthy subjects // Am J Gastroenterol. 1999. – Vol.94(5). – P.1192-1196151.Penagini R., Mangano M., Bianchi P.A. // Effect of increasing thefat content but not the energy load of a meal on gastro-oesophageal reflux andlower oesophageal sphincter motor functionGut 1998.
– Vol.42(3). – P.330-333152.Peter CS, Wiechers C, Bohnhorst B et al. Detection of small bolusvolumes using multiple intraluminal impedance in preterm infants. J PediatrGastroenterol Nutr. 2003;36(3):381–384.153153.Pilic D, Hankel S, Koerner-Rettberg C et al. The role of baselineimpedance as a marker of mucosal integrity in children with gastro esophagealreflux disease. // Scand J Gastroenterol.
2013. - 48(7). – P.785–793.154.Rabinowitz SS, Goli S, Xu J et al. Lack of correlation betweenobesity and gastroesophageal reflux disease (GERD) in a pediatric cohort. //Open Journal of Pediatrics. 2013. - 3(4). – P.317-323.155.Richter JE, Rubenstein JH. Presentation and Epidemiology ofGastroesophageal Reflux Disease. // Gastroenterology. 2018. - 154(2). – P.267276.156.Rudolph C.D., Mazur L.J., Liptak G.S. et al. Guidelines forevaluation and treatment of gastroesophageal reflux in infants and children:recommendations of the North American Society for Pediatric Gastroenterologyand Nutrition // J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
